Cancer Immunology, Immunotherapy has the basic aim of keeping readers informed of the latest research results in the fields of oncology and immunology. As knowledge expands, the scope of the journal has broadened to include more of the progress being made in the areas of biology concerned with biological response modifiers. This helps keep readers up to date on the latest advances in our understanding of tumor-host interactions. The journal publishes short editorials including ''position papers,'' general reviews, original articles, and short communications, providing a forum for the most current experimental and clinical advances in tumor immunology. Tumor immunologists, clinical oncologists, virologists, and medical microbiologists involved in the development of methods of treatment and therapies for cancer patients will benefit from the information contained in this journal. Cancer Immunology, Immunotherapy is the official journal of the Association for Cancer Immunotherapy.